Bibliography
- DeBoer M. Animal models of anorexia and cachexia. Expert Opin Drug Discov 2009;4(11):1145-55
- Springer J, von Haehling S, Anker SD. The need for a standardized definition for cachexia in chronic illness. Nat Clin Pract Endocrinol Metab 2006;2:416-7
- Evans WJ, Morley JE, Argiles J, Cachexia: a new definition. Clin Nutr 2008;27:793-9
- Inagaki J, Rodriguez V, Bodey GP. Proceedings: causes of death in cancer patients. Cancer 1974;33:568-73
- Muscaritoli M, Costelli P, Bossola M, Effects of simvastatin administration in an experimental model of cancer cachexia. Nutrition 2003;19:936-9
- Piffar PM, Fernandez R, Tchaikovski O, Naproxen, clenbuterol and insulin administration ameliorates cancer cachexia and reduce tumor growth in Walker 256 tumor-bearing rats. Cancer Lett 2003;201:139-48
- Busquets S, Fuster G, Ametller E, Resveratrol does not ameliorate muscle wasting in different types of cancer cachexia models. Clin Nutr 2007;26:239-44
- Nagaya N, Uematsu M, Kojima M, Chronic administration of ghrelin improves left ventricular dysfunction and attenuates development of cardiac cachexia in rats with heart failure. Circulation 2001;104:1430-5
- Akashi YJ, Palus S, Datta R, No effects of human ghrelin on cardiac function despite profound effects on body composition in a rat model of heart failure. Int J Cardiol 2008;22:22
- Palus S, Akashi Y, von Haehling S, The influence of age and sex on disease development in a novel animal model of cardiac cachexia. Int J Cardiol 2009;133:388-93
- Nicholson JR, Kohler G, Schaerer F, Peripheral administration of a melanocortin 4-receptor inverse agonist prevents loss of lean body mass in tumor-bearing mice. J Pharmacol Exp Ther 2006;317:771-7
- Bauhofer A, Witte K, Celik I, Sickness behaviour, an animal equivalent to human quality of life, is improved in septic rats by G-CSF and antibiotic prophylaxis. Langenbecks Arch Surg 2001;386:132-40
- Baumans V. Use of animals in experimental research: an ethical dilemma? Gene Ther 2004;11:S64-6